会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • GENES ENCODING NEMATODE TOXINS
    • 基因编码NEMATODE毒素
    • US20130133107A1
    • 2013-05-23
    • US13747740
    • 2013-01-23
    • Athenix Corporation
    • Cheryl L. PetersBrian Vande BergBrian CarrJulia T. DaumVadim BeilinsonSandra VolrathCandace PoutreKimberly Sampson
    • C12N15/82
    • C12N15/8241C12N9/0059C12N9/0071C12N15/8285C12Y110/03001C12Y114/18001Y02A40/164
    • Compositions and methods for conferring nematicidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions including a coding sequence for nematicidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also include transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated nematicidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules including nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:4, 5, 8, 9, 13, 14, 47, 48, or 49, the nucleotide sequence set forth in SEQ ID NO:1, 2, 3, 6, 7, 10, 11, 12, 15, 45, or 46, as well as variants and fragments thereof.
    • 提供了赋予细菌,植物,植物细胞,组织和种子的杀线虫活性的组合物和方法。 提供了包含杀线虫多肽的编码序列的组合物。 编码序列可用于DNA构建体或表达盒中,用于在植物和细菌中转化和表达。 组合物还包括转化的细菌,植物,植物细胞,组织和种子。 特别地,提供了分离的杀线虫剂核酸分子。 另外,包括对应于多核苷酸的氨基酸序列。 特别地,本发明提供了分离的核酸分子,其包括编码SEQ ID NO:4,5,8,9,13,14,77,48或49所示氨基酸序列的核苷酸序列,所列出的核苷酸序列 在SEQ ID NO:1,2,3,6,7,10,11,12,15,45或46中,以及其变体和片段。
    • 8. 发明授权
    • Compositions and methods relating to reduction of symptoms of autism
    • 与减少自闭症症状有关的组成和方法
    • US06821514B2
    • 2004-11-23
    • US10313790
    • 2002-12-06
    • Devin B. Houston
    • Devin B. Houston
    • A61K3848
    • C12N9/48A61K38/4813C12N9/0059C12Y110/03001C12Y304/14005A61K2300/00
    • Methods and compositions that can reduce the symptoms of autism in a human patient comprising administering a physiologically effective amount of one or both of a purified casomorphin inhibitor selected from the group consisting of a casomorphinase and a casomorphin ligand, and a physiologically effective amount of a purified gluteomorphin inhibitor selected from the group consisting of a gluteomorphinase and a gluteomorphin ligand, to a human patient in sufficient quantities to reduce the effects of the autism. In some embodiments, the compositions and methods further comprise a physiologically effective amount of an enkephalin inhibitor, preferably an enkephalinase, and a physiologically effective amount of an endorphin inhibitor, preferably an endorphinase.
    • 可以减轻人类患者自闭症症状的方法和组合物,其包括给予生理学有效量的选自下列药物的一种或两种纯化的casomorphin抑制剂:胱天肽酶和casomorphin配体,以及生理有效量的纯化 麝香草素抑制剂,选自糠醛吗啡酶和钆蓝霉素配体,以足够的量向人类患者减轻自闭症的作用。 在一些实施方案中,组合物和方法还包含生理有效量的脑啡肽抑制剂,优选脑啡肽酶和生理有效量的内啡肽抑制剂,优选内啡肽。